ArticleDigestive diseases and sciences2011

Prediction of sustained virological response to combination therapy with pegylated interferon alfa and ribavirin in patients with genotype 3 chronic hepatitis C.

S K Tohra et al.PubMed ↗Publisher ↗

No numbers read from the abstract.